Insmed
INSM
101.74
-3.49
-3.32%
Insmed
US · INSM
#794 by market cap
Listed 1970
101.74
-3.49
-3.32%
Live - 5344 symbols - heartbeat 462s ago
· 2026-10-08 08:14
Pre-market
101.69
-0.05%
After-hours
103.00
+1.23%
Overnight
101.99
+0.25%
- Market cap
- 22.22B
- P/E (TTM)i
- -24.69
- P/Bi
- 29.33
- EPSi
- -6.42
- Div yieldi
- 0.00%
- 52W posi
- 9%
Reader sentiment
Are you bullish or bearish on INSM?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 20 analysts
Buy
Avg price target
198.21 +94.8%
Price target rangecurrent 101.74
Low169.00
Avg198.21
High243.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-30 | Barclays | -- | BUY | 207.00 |
| 2026-09-28 | J.P. Morgan | -- | BUY | 175.00 |
| 2026-09-25 | Morgan Stanley | -- | BUY | 218.00 |
| 2026-09-24 | Goldman Sachs | -- | BUY | 188.00 |
| 2026-09-22 | Mizuho Securities | -- | BUY | 195.00 |
| 2026-09-21 | BofA Securities | -- | BUY | 214.00 |
| 2026-09-18 | Morgan Stanley | -- | BUY | 218.00 |
| 2026-09-15 | Roth MKM | -- | BUY | 198.00 |
| 2026-09-11 | Morgan Stanley | -- | BUY | 218.00 |
| 2026-08-25 | RBC Capital | -- | BUY | 195.00 |
| 2026-08-24 | Mizuho Securities | -- | BUY | 195.00 |
| 2026-08-24 | Morgan Stanley | -- | BUY | 218.00 |
| 2026-08-17 | BMO Capital | -- | BUY | 192.00 |
| 2026-08-14 | Morgan Stanley | -- | BUY | 218.00 |
| 2026-08-10 | Truist Financial | -- | BUY | 195.00 |
| 2026-08-10 | H.C. Wainwright | -- | BUY | 220.00 |
| 2026-08-10 | J.P. Morgan | -- | BUY | 175.00 |
| 2026-08-07 | UBS | -- | BUY | 172.00 |
| 2026-08-07 | BofA Securities | -- | BUY | 214.00 |
| 2026-08-07 | Evercore | -- | BUY | 170.00 |
| 2026-08-07 | Roth MKM | -- | BUY | 212.00 |
| 2026-08-07 | Barclays | -- | BUY | 237.00 |
| 2026-08-06 | TD Cowen | -- | BUY | 243.00 |
| 2026-08-06 | Cantor Fitzgerald | -- | BUY | 235.00 |
| 2026-08-06 | Wells Fargo | -- | BUY | 169.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
D+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Morgan Stanley moved from Hold to Buy on 2026-03-30.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-03-30 | Morgan Stanley | HOLD → BUY | 212.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±13.43% | +33.86% (beat) |
| 2026/Q1 | 2026-05-07 | -- | ±11.12% | -23.41% (beat) |
| 2025/Q4 | 2026-02-19 | -- | ±6.53% | +6.54% (beat) |
| 2025/Q3 | 2025-10-30 | -- | ±9.58% | +16.33% (beat) |
| 2025/Q2 | 2025-08-07 | -- | ±11.27% | -1.76% (in line) |
| 2025/Q1 | 2025-05-08 | -- | ±12.74% | -3.88% (in line) |
| 2024/Q4 | 2025-02-20 | -- | ±6.45% | -0.26% (in line) |
| 2024/Q3 | 2024-10-31 | -- | ±9.82% | -4.29% (in line) |
| 2024/Q2 | 2024-08-08 | -- | ±10.20% | +1.16% (in line) |
| 2024/Q1 | 2024-05-09 | -- | ±21.80% | +1.46% (in line) |
| 2023/Q4 | 2024-02-22 | -- | ±11.03% | -3.86% (in line) |
| 2023/Q3 | 2023-10-26 | -- | ±14.61% | +0.39% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:14:38 · For reference only, not investment advice and not tailored to your situation.